51 – 60 of 494
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999 : a population-based study
(
- Contribution to journal › Article
-
Mark
Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
(
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
-
Mark
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme
(
- Contribution to journal › Article
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Analytical performance of aPROMISE : automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting
(
- Contribution to journal › Article
-
Mark
Increasing rates of urinary- and bloodstream infections following transrectal prostate biopsy in South Sweden
(
- Contribution to journal › Article
-
Mark
Community-onset urosepsis : incidence and risk factors for 30-day mortality–a retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Noninvasive detection of any-stage cancer using free glycosaminoglycans
(
- Contribution to journal › Article
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
(
- Contribution to journal › Article